A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research
G. Emerens Wensink(Utrecht University), Jeanine M.L. Roodhart(University Medical Center Utrecht), Emre Küçükköse(Utrecht University), Geraldine R. Vink(Utrecht University), Miriam Koopman(Utrecht University), Marinde J. G. Bond(Utrecht University), Anne M. May(Utrecht University), Onno Kranenburg(Utrecht University)
Cited by 38
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|609
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
|Journal of Clinical Oncology|2022|608
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
|British Journal of Cancer|2009|518